A group of Saccharomyces cerevisiae mutants has been previously reported which, when initially isolated as multiple mutants from a parental strain possessing the methionine requirement met-2a, shared the common characteristic of failing to respond to supplementation with Sadenosylmethionine, a compound which supports the growth of strains carrying only the met-2a mutation (6) . All of the isolates were given designations of ai. Intracellular S-adenosylmethionine pool formation, and the subsequent incorporation of its methyl groups into cellular protein were observed in both met-2a and met-2a ai-i strains when S-adenosylmethionine was present in the medium (6) . All of the isolates retained the potential to synthesize methionine from S-adenosylmethionine via the S-adenosylmethionine: homocysteine methyltransferase (6) . None of the precursors of yeast methionine biosynthesis tested, nor S-adenosylhomocysteine or methylthioadenosine, will support the growth of met-2a strains (6) . The positive growth response obtained with S-adenosylhomocysteine alone reported earlier for the met-2a ade strain was a typographical error (6) . The ai-i mutant was the only strain selected for detailed analysis at that time (6) . A detailed investigation of another of these isolates, originally termed ai-3, has since been initiated, and the mutation was found to be different from that of the ai-i isolate. In view of the relationship of the ai-3 mutation to permeability, we have redesignated this mutation samp3. Whereas strains carrying the ai-i mutation are inhibited by both S-adenosylmethionine and S-adenosylhomocysteine, the sam-p3 mutation apparently involves a genetic aberration affecting the uptake of these two compounds. The latter mutation is the subject of this report.
MATERIALS AND METHODS
Organisms and media. Strain 8038 (ura met-2a samp3) was isolated from strain 80BM-1 (ura met-2a) after ultraviolet light treatment and replica plating as described earlier (6) . Strains 22B (met-6), ET48 (met-3), and JB4 (met-5 ade) were obtained from R. K. Mortimer, University of California, Berkeley. The latter organism will grow on homoserine plus adenine or on methionine plus threonine plus adenine. Methionine may be replaced with S-adenosylmethionine or S-adenosylhomocysteine in the latter case. The threonine and adenine deficiencies are designated by R. K. Mortimer as thr-2 and ade-2, respectively. The met-2a, met-3, and met-6 mutations block the one carbon transfer at different steps in the tetrahydrofolate system for methionine biosynthesis. Other mutant designations will be discussed.
Medium B is a modification of Wickerham's synthetic medium (7) containing, per liter: 20 g of glucose; 2 g of (NH4)2SO4; 875 mg of KH2PO4; 125 mg of K2HPO4; 100 mg of NaCI; 100 mg of CaCl2 2H20; 500 mg of MgSO4-7H20; 2 The 2-hr uptake experiments employed cells initially preadapted as described above. However, before addition of radioactive supplements, they were incubated for an additional 16 hr in medium B plus 0.2 umole each of L-methionine and uracil per ml followed by a 4-hr incubation in medium B plus 0.2 Amole of uracil per ml. Cell concentrations were adjusted to the desired experimental concentration. Radioactive supplements were then introduced. Samples were removed at the reported intervals, collected on membrane filters (Millipore Corp.), and then immediately washed with distilled water. They were then dryed and assayed in a Nuclear-Chicago gas-flow planchett counter (efficiency, 30 to 35%).
Chemicals. Purified, unlabeled S-adenosyl-L-methionine and S-adenosyl-L-homocysteine (4) were prepared in this laboratory. All other compounds were obtained from commercial sources.
RESULTS
Uptake studies. On the basis of information available at the time of an earlier report, the sam-p3 strain was not clearly distinguishable from that designated as ai-i (6). Those results showed that both S-adenosylmethionine and Sadenosylhomocysteine inhibited the growth of ai-1 strains. Methionine gave a marginal reversal of these effects, and S-methylmethionine was of no benefit to ai-i strains when grown in the presence of the inhibitors. Similar tests on the samp3 strain have shown that this mutation is not the same as the ai-i. Neither S-adenosylmethionine or S-adenosylhomocysteine prevented Smethylmethionine from supporting the growth of an met-2a sam-p3 strain (results presented in this report), and methionine supported maximal growth in the presence of the inhibitors of ai-i. This suggested that, rather than being inhibited by S-adenosylmethionine, the sam-p3 strain may have had an impaired ability to take up the sulfonium compound.
To test this possibility, the ability of the original met-2a sam-p3 isolate to grow on and take up adenosylmethionine and methionine was compared with that of the parental strain. These results are shown in Fig. 1 . For at least 12 hr strain 8038 showed no detectable uptake when supplied with S-adenosylmethionine. Similar growth and uptake patterns were shown by both strains in the presence of 0.1 ,umole of L-methionine-14COOH per ml. A small amount of growth was detected in both strains in the absence of supplements. This was probably due to residual methionine in the cells at the beginning of the experiment. Although S-adenosylmethionine allowed strain 80BMI to maintain a growth rate equal to that of methionine during the early hours of the experimental interval, the compound did not support the growth of strain 8038.
The uptake of S-adenosylmethionine, S-methylmethionine, and methionine over a short interval at higher cell concentrations is shown in Fig. 2 and 3 . Most of the residual intracellular methionine was eliminated from the cells by a 4-hr starvation period in the absence of methionine before the addition of supplements. It is apparent that the sam-p3 mutation severely restricts the capacity of strain 8038 to take up S-adenosylmethionine (Fig. 2) . The uptake pattern for methionine and S-methylmethionine was not similarly affected. The inclusion of S-adenosylmethionine with either the alternate sulfonium compound, S-methylmethionine, or with methionine did not affect the uptake of these compounds in strain 8038 (Fig. 2) . The parental strain showed a normal uptake pattern with S-adenosylmethionine-14CH3 under the above conditions (Fig.   3 ).
Genetics of the sam-p3 mutation. If the absence of growth and uptake of S-adenosylmethionine involved a mutation which restricted the ability of sam-p3 strains to take up this sulfonium compound, any disadvantage to the cell should be removed by eliminating the methionine requirement. Tetrad analysis of the sam-p3 mutation is shown in Table 1 . Unlike the ai-i mutation reported earlier (6), the sam-p3 mutation is detectable only in strains also requiring methionine. To prove that the strains actually possessed the samp3 mutation, although undetectable in this test system, it was necessary to outcross suspected strains with other strains containing methionine markers. In addition, valuable evidence describing the specificity of the mutation might be gained by preparing strains which contained only the adenine and sam-p3 markers. If S-adenosylmethionine (which will correct adenine, methionine, and homocysteine deficiencies) could not be taken up, it should not support the growth of either met-2a sam-p3 or ade sam-p3 strains. The results of these experiments are summarized in Table 2 . From crosses employing strains which were assumed to possess the sam-p3 mutation through tetrad analysis, the sam-p3 mutation was readily detected not only in combination with any of the met markers employed but also in combination with the ade marker. In strains containing only the homoserine, methionine, or adenine markers, the sam-p3 mutation was present approximately half of the time. These results show that the sam-p3 segregates independently of the markers tested here and are consistent with the assumption that the sam-p3 is a single, chromosomal mutation. S-adenosylmethionine alone will not support the growth of any of the mutants requiring and normally utilizing its major moieties when the sam-p3 mutation is also present. Table 3 shows the results of several tests which compare the ability of methionine, adenine, Sadenosylhomocysteine, S-adenosylmethionine, and S-methylmethionine to support the growth of selected genetic combinations, with and without the sam-p3 mutation. It should be restated that adenine, S-adenosylmethionine, and Sadenosylhomocysteine all support the growth of the adenine-requiring strains that we have thus far tested. Methionine, S-adenosylmethionine, and S-methylmethionine support the growth of all the methionine-dependent strains in our collection. S-adenosylhomocysteine supports growth of all homocysteine-and cysteine-requiring strains we have tested. Under appropriate conditions, the adenosylsulfonium compound and its demethylated analogue will support the growth of met-S mutants. As seen in Table 3 , the only compounds which are incapable of supporting the growth of adenine, methionine, or homoserine auxotrophs which also contain the sam-p3 mutation are S-adenosylmethionine and S-adenosylhomocysteine. These compounds do not inhibit the utilization of adenine, methionine, S-methylmethionine, or homoserine by the samp3 strains.
Removal of ammonium ions. In several yeastpermease mutations reported, the detection of the permease aberration is dependent on the presence of ammonium ions (1) (2) (3) . With the a Known genotypes of 838E8 segregants were 838E8-B3 (a met-3 sam-p3) and 838E8-H4 (a met-3 sam-p3); those with suspected sam-p3 were 838E8-LI (a ura sam-p3) and 838E8-J4 (a ura sam-p3).
I The sam-p3 was detectable by absence of growth on S-adenosylmethionine (AM), but only when in combination with any or all of the markers met-2a, met-3, met-6, met-5, or ade. The other marker, ura, was included for comparison.
c Percentages were calculated from isolates containing no other markers. sam-p3 mutation, the replacement of ammonium ions with proline in medium B agar does not correct the inability of S-adenosylmethionine to support the growth of met-2a sam-p3 mutants.
DISCUSSION
The results obtained show that the sam-p3 mutation severely restricts the ability of the yeast cell to take up S-adenosylmethionine and apparently involves a relatively specific transport system thus far limited to S-adenosylmethionine and S-adenosylhomocysteine. In growth response tests, the amount of S-adenosylmethionine entering the sam-p3 cell was apparently insufficient to satisfy methionine (met-2a), adenine (ade-2), or homoserine (met-S) requirements. Methionine and S-methylmethionine uptake in the sam-p3 strain were unaffected by either the mutation or the presence of S-adenosylmethionine. The uptake of adenine, homoserine, methionine, Smethylmethionine, uracil, and threonine are apparently unaffected by the mutation.
As would be predicted, the sam-p3 mutation when present alone has no detectable effect on the growth of the organism. It is a single, chromosomal mutation, segregating independently from all the mutations tested thus far. Unlike several other permease mutations reported earlier (1-3), the detection of the sam-p3 mutation is not dependent on the presence of ammonium ions. Although distinguishable on the latter basis from the permease mutants reported by those workers, it does strongly support their contention that S. cerevisiae possesses highly selective permeability mechanisms. 
